Jack Lief

Executive Director at BIOCOM

Jack Lief

Jack Lief

Executive Director at BIOCOM

Overview
Career Highlights

BIOCOM
Aires Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc.

RelSci Relationships

590

Number of Boards

9

Birthday

1946

Age

73

Relationships
RelSci Relationships are individuals Jack Lief likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Arena Pharmaceuticals, Inc.

Relationship likelihood: Strong

Director & Co-Founder at BIOCOM

Relationship likelihood: Strong

President & Chief Executive Officer at BIOCOM

Relationship likelihood: Strong

Chief Executive Officer at Nabriva Therapeutics Plc

Relationship likelihood: Strong

Chief Executive Officer at Synthetic Genomics, Inc.

Relationship likelihood: Strong

Co-Founder at Neurelis, Inc.

Relationship likelihood: Strong

Chairman-Elect at BIOCOM

Relationship likelihood: Strong

President & Chief Executive Officer at ReqMed Co., Ltd.

Relationship likelihood: Strong

Dean at University of San Diego - School of Law

Relationship likelihood: Strong

Interim President & Chief Executive Officer at Intersect ENT, Inc.

Relationship likelihood: Strong

Paths to Jack Lief
Potential Connections via
Relationship Science
You
Jack Lief
Executive Director at BIOCOM
Education
B.A

Rutgers, The State University of New Jersey, is a leading national research university and the state’s preeminent, comprehensive public institution of higher education. Rutgers is dedicated to teaching that meets the highest standards of excellence; to conducting research that breaks new ground; and to providing services, solutions, and clinical care that help individuals and the local, national, and global communities where they live. Founded in 1766, Rutgers teaches across the full educational spectrum: preschool to precollege; undergraduate to graduate; postdoctoral fellowships to residencies; and continuing education for professional and personal advancement.

M.S. in Psychology (Experimental & Neurobiology)

Lehigh is a premier residential research university, ranked in the top tier of national research universities each year. We are a coeducational, nondenominational, private university that offers a distinct academic environment of undergraduate and graduate students from across the globe. Our university offers majors and programs in four colleges: The College of Arts and Sciences, The College of Business and Economics, The College of Education and The P.C. Rossin College of Engineering and Applied Science. More than 4,700 undergraduate and 2,000 graduate students call Lehigh "home." Located in Pennsylvania’s scenic Lehigh Valley, the campus is in close proximity to both New York City and Philadelphia. Lehigh is comprised of 2,358 acres, making it one of the largest private universities in the country. The Asa Packer Campus, Mountaintop Campus, and Murray H. Goodman Campus are contiguous. In 2012, the university received a Stabler Foundation gift of 755 acres in nearby Upper Saucon Township. Since 1865, generations of students have chosen Lehigh for their educational experience. They know Lehigh is a place where they can make strong personal connections with faculty, conduct research in diverse fields of study, thrive in a dynamic campus community, form lasting bonds with Lehigh alumni, and learn from their own life experiences.

Career History
Executive Director
2005 - Current

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.

Director
Current

ReqMed Co., Ltd. engages in drug development and consulting services. Its projects include development of pentosan polysulfate which alleviate pain symptoms of osteoarthritis, and eltoprazine which are used in the diseases such as attention-deficit hyperactivity disorder, cognitive impairment associated with schizophrenia and dyskinesia associated with Parkinson disease. The firm's clients include pharmaceutical and bio-pharmaceutical companies. The company was founded by Tadashi Matsumoto on May 12, 1998 and is headquartered in Machida, Japan.

Co-Founder
1997 - 2015

Corporate Overview Our Focus We are a biopharmaceutical company focused on discovering, developing and commercializing novel drugs for weight management, cardiovascular disease, inflammation and other disorders. In June 2012, the US Food and Drug Administration (FDA) approved our internally discovered drug, BELVIQ® (lorcaserin HCl). Click here for additional information. We are also seeking regulatory approval for BELVIQ in additional territories. Regulatory agencies outside of the US will independently review BELVIQ. In addition to BELVIQ, our internally discovered, oral drug candidates include APD811, an agonist of the prostacyclin receptor intended for the treatment of pulmonary arterial hypertension; temanogrel, an inverse agonist of the serotonin 2A receptor intended for the treatment of thrombotic diseases; APD334, an agonist of the S1P1 receptor intended for the treatment of autoimmune diseases; APD371, an agonist of the cannabinoid receptor 2 intended for the treatment of pain; GPR119 agonists, intended for the treatment of type 2 diabetes; and nelotanserin, an inverse agonist of the serotonin 2A receptor, which we previously studied for the treatment of insomnia

Boards & Committees
Member, Board of Directors
Prior

Part of Grifols SA /Grifols Family/, Alpha Therapeutic Corp. is a company headquartered in Los Angeles, CA. The firm develops of plasma derived products.

Political Donations
$2,250
2012

Former Representative from California's 50th Congressional District

$500
2009

Former Representative from California's 50th Congressional District

$1,000
2004

Founder at WBB Securities LLC

Transactions
Details Hidden

Arena Pharmaceuticals, Inc. issued Common Stock

Details Hidden

Arena Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Arena Pharmaceuticals, Inc. raised money in a private placement transaction

Investments
Details Hidden

Corporate Overview Our Focus We are a biopharmaceutical company focused on discovering, developing and commercializing novel drugs for weight management, cardiovascular disease, inflammation and other disorders. In June 2012, the US Food and Drug Administration (FDA) approved our internally discovered drug, BELVIQ® (lorcaserin HCl). Click here for additional information. We are also seeking regulatory approval for BELVIQ in additional territories. Regulatory agencies outside of the US will independently review BELVIQ. In addition to BELVIQ, our internally discovered, oral drug candidates include APD811, an agonist of the prostacyclin receptor intended for the treatment of pulmonary arterial hypertension; temanogrel, an inverse agonist of the serotonin 2A receptor intended for the treatment of thrombotic diseases; APD334, an agonist of the S1P1 receptor intended for the treatment of autoimmune diseases; APD371, an agonist of the cannabinoid receptor 2 intended for the treatment of pain; GPR119 agonists, intended for the treatment of type 2 diabetes; and nelotanserin, an inverse agonist of the serotonin 2A receptor, which we previously studied for the treatment of insomnia

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jack Lief. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jack Lief's profile does not indicate a business or promotional relationship of any kind between RelSci and Jack Lief.